comparemela.com

Latest Breaking News On - செல்லுலார் சிகிச்சை - Page 13 : comparemela.com

Inside La Prairie s Platinum Rare Haute-Rejuvenation Protocol

Share La Prairie’s quest for longevity resulted in the latest Platinum Rare Haute-Rejuvenation Protocol, an intensive treatment at the apex of Dr Paul Niehan’s pioneering science. Written into myths and legends, the quest for eternal youth seemed little more than a dream for many. But not for Dr Paul Niehans, who in 1931 was convinced that the science to unlock the secret of rejuvenation already existed. Very quickly, Niehans developed Cellular Therapy, famously proclaiming that it’s “not only about adding years to life, but life to years”, and wrote his findings into a book. At Clinique La Prairie, on the serene shores of Lac Léman, Niehans offered his treatment to a privileged few – Pope Pius XII, Charlie Chaplin and Marlene Dietrich were just some of his esteemed clients.

Hackensack Meridian Health Publication: COVID-19 Convalescent Plasma with Greater Antibody Levels is Safe and Shows Promise

Share this article Share this article HACKENSACK, N.J., March 10, 2021 /PRNewswire/  Convalescent plasma, the use of survivors antibodies transfused into sick COVID-19 patients is safe and significantly improves clinical outcomes when using high levels of antibodies, according to a new publication by scientists at Hackensack Meridian Health, New Jersey s largest and most comprehensive health network. The treatment was safe, transferred the survivors antibodies, and did not prevent the recipients from making their own antibodies, according to the results published recently in the journal We have developed this technique and methodology to save the lives of patients, said Michele Donato, M.D., FACP, CPE, chief of Stem Cell Transplantation and Cellular Therapy at John Theurer Cancer Center at Hackensack University Medical Center, and who is leading the study. We believe our hard work is paying off.

AHN Cancer Institute Opens Genomics Facility Offering Patients Next-Generation Gene Sequencing to Guide Treatment Decisions

AHN Cancer Institute Opens Genomics Facility Offering Patients Next-Generation Gene Sequencing to Guide Treatment Decisions Share Article Pittsburgh-based Allegheny Health Network (AHN) Cancer Institute has opened a new Clinical Genomics Laboratory, offering comprehensive, advanced, in-house genomic testing that guides doctors in selecting treatments to give cancer patients their best chance at a good outcome. William LaFramboise, PhD, Chief Genomics Technology Officer, Allegheny Health Network, and David Bartlett, MD, Chair, AHN Cancer Institute, in AHN s new Clinical Genomics Laboratory We believe that offering on-site genomic testing offers a number of advantages to our patients, including a quicker turnaround time and better stewardship of our patients’ samples. - David L. Bartlett, MD, Chair, AHN Cancer Institute

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.